戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 le ligand control over the presentation of a peptide aptamer.
2 , comparable with that of recently described peptide aptamers.
3 o RNA aptamers and the low docking scores of peptide aptamers.
4 ajor Geminiviridae genera and identified two peptide aptamers (A22 and A64) that interact strongly wi
5                                We identified peptide aptamers against Dishevelled (Dsh) and beta-cate
6 ation-specific surface immobilization of the peptide aptamer and to ensure exposure of the binding si
7 cificity in kinetic analysis biomechanics in peptide aptamers and GO sheets.
8                                Together with peptide aptamers and other Ub affinity-based approaches,
9                   In an effort to extend the peptide aptamer approach, we have developed a scaffold p
10                      Using mutagenesis and a peptide aptamer approach, we pinpointed phenylalanine 79
11                                              Peptide aptamers are peptides constrained and presented
12                                        These peptide aptamers are target-specific peptides expressed
13           Here we explore the ability to use peptide aptamers as in vivo inhibitors by expressing apt
14                  Here we describe the use of peptide aptamer-based affinity chromatography coupled wi
15                        Our results show that peptide aptamers bear some analogies with monoclonal ant
16                                              Peptide aptamers, being peptide recognition moieties pre
17 t signaling, we developed three Smad-binding peptide aptamers by introducing Smad interaction motifs
18        The results suggest that Smad-binding peptide aptamers can be developed to selectively inhibit
19                                              Peptide aptamers can be identified that disrupt a proces
20                                     Specific peptide aptamers can be used in place of expensive antib
21 ivery to cancers, with antibodies, proteins, peptides, aptamers, carbohydrates and small molecules al
22                                          The peptide aptamers characterized in these studies represen
23                             We report that a peptide aptamer designed to inhibit the binding between
24                                            A peptide aptamer DVFLGDVFLGDEC (DD) that can recognize S.
25                             We expressed two peptide aptamers, each of which specifically recognizes
26 o orders of magnitude compared to the linear peptide aptamer, estimating K(D) as 10.1 nM, which is th
27         In this study, we selected 16 of the peptide aptamers for further analysis in yeast two-hybri
28 ate the use of surface-immobilized, oriented peptide aptamers for the detection of specific target pr
29                                  We selected peptide aptamers from combinatorial libraries that disru
30       Combined, our results demonstrate that peptide aptamers generated by yeast two-hybrid methods c
31         The thiol group from cysteine in the peptide aptamer, i.e., DD, can interact with gold ions t
32 ults of these experiments showed that all 16 peptide aptamers interact with all or most of the Rep pr
33                 Here, we describe the use of Peptide Aptamer Interference (PAPTi) approach for struct
34                                     Although peptide aptamer is an attractive candidate for a molecul
35 across potentially many thousands of arrayed peptide aptamers is predicted to simplify the production
36                           Here we describe a peptide aptamer isolated from a combinatorial library th
37 antage that it can be applied for generating peptide aptamer libraries at sites within proteins witho
38 ait in a yeast two-hybrid screen of a random peptide aptamer library constrained in the active site o
39                                              Peptide aptamer microarrays are shown to detect low leve
40                             We conclude that peptide aptamer microarrays represent a promising tool f
41 or the future creation of highly multiplexed peptide aptamer microarrays that will be compatible with
42                                    E6 and E7 peptide aptamer microarrays were probed with fluorescenc
43                                 In addition, peptide aptamer mimicking RAD51(pY315) fragment, but not
44                Forward genetic analysis with peptide aptamer "mutagens" should be particularly useful
45 tates discovery of sodium channel inhibitory peptide aptamers (NaViPA) for adeno-associated virus-med
46 s issue of the JCI, Shin et al. identified a peptide aptamer, NaViPA1, carrying a short polybasic mot
47 employ antibodies or small molecules such as peptides, aptamers or other small molecules require that
48 ough the modification of the NP surface with peptides, aptamers, or other motifs that specifically re
49                                              Peptide aptamers provide probes for biological processes
50 tion of ROS-scavenging mitochondria-targeted peptide aptamer reduced genomic instability.
51 that the inactivation of protein function by peptide aptamers represents a viable approach to the und
52 e a rational approach to the design of a new peptide aptamer scaffold.
53                                              Peptide aptamers specific for cellular proteins included
54 rticle describes the performance of a set of peptide aptamers specific for the human papillomavirus (
55 t KD for the interaction between an oriented peptide aptamer ST(cys+)_(pep9) and the target protein C
56 , we demonstrate the high selectivity of the peptide aptamer STM_(pep9) by exposing surface-immobiliz
57                               The success of peptide aptamer technology is critically dependent on th
58                   Thus, we have identified a peptide aptamer that affects a function of BCL-6 that is
59 of functional screening in yeast to identify peptide aptamers that are functional in mammalian cells;
60  In an earlier study, we identified a set of peptide aptamers that bind to Rep and reduce viral repli
61 n identify bridge or connecting proteins and peptide aptamers that discriminate between closely relat
62 sed a two-bait two-hybrid system to identify peptide aptamers that distinguish allelic forms of H-Ras
63 ibe the characterization of ligand-regulated peptide aptamers that interact with and inhibit the 5'-A
64                                Specifically, peptide aptamers that recognize highly related protein p
65 BCL-6 in lymphoma, we screened a library for peptide aptamers that specifically bind to BCL-6 POZ and
66 rolling the early nuclear cycles we isolated peptide aptamers that specifically bind to cyclin J and
67 ology provides a simple way to isolate small peptide aptamers that specifically recognize and strongl
68 d graphene oxide (GO) sheets with a specific peptide aptamer to create a novel, simple and label-free
69 an in vitro selection technique, to identify peptide aptamers to a protein target.
70                             The use of small peptide aptamers to competitively inhibit protein intera
71 stablished the efficacy of using Rep-binding peptide aptamers to develop crops that are resistant to
72  disrupting Smad-dependent signaling using a peptide aptamer, Trx-SARA, which comprises a rigid scaff
73                                        These peptide aptamers were designed to mimic the recognition
74 pitope when presented in a protein, the anti-peptide aptamers were found to specifically bind to Rev.
75           Here, we report the integration of peptide aptamers with extended gate metal-oxide-semicond
76            Here we describe the isolation of peptide aptamers with optimized versions of this motif b